Company / Interest Expense
Perspective Therapeutics, Inc. Interest Expense History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
-
FY2022
5-year range
$0 / $1.0K
FY2018-FY2022
Trend
-
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $2,000 to $0 over the past 5 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Peak interest expense was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 5.43 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $1.0K | -50.0% |
| FY2017 | $2.0K | +126.5% |
| FY2016 | $883 | +12514.3% |
| FY2015 | $7 | - |
| FY2014 | - | - |
| FY2013 | - | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026